Type 1 diabetes (TID) is an autoimmune metabolic condition in which, β-cells of the pancreas are destroyed by the immune cells, hence patients with T1D require administration of exogenous insulin to control blood glucose concentrations [2,3,4]. This evidence concerns the gene INS and type 1 diabetes mellitus.